In vitro and in vivo evaluation of a melamine dendrimer as a vehicle for drug delivery.
about
Melamine Induces Oxidative Stress in Mouse OvaryGadolinium MRI contrast agents based on triazine dendrimers: relaxivity and in vivo pharmacokinetics.Biological assessment of triazine dendrimer: toxicological profiles, solution behavior, biodistribution, drug release and efficacy in a PEGylated, paclitaxel constructComparison of MRI properties between derivatized DTPA and DOTA gadolinium-dendrimer conjugates.Biodegradable Janus nanoparticles for local pulmonary delivery of hydrophilic and hydrophobic molecules to the lungs.Preparation, characterization and in vivo assessment of Gd-albumin and Gd-dendrimer conjugates as intravascular contrast-enhancing agents for MRI.Preparation of cystamine core dendrimer and antibody-dendrimer conjugates for MRI angiographyNanotechnology safety concerns revisited.Use of degradable and nondegradable nanomaterials for controlled release.Advances of cancer therapy by nanotechnology.Identification of Diamine Linkers with Differing Reactivity and their Application in the Synthesis of a Melamine Dendrimers.Effects of nanomaterial physicochemical properties on in vivo toxicity.PEG-conjugated PAMAM dendrimers mediate efficient intramuscular gene expression.Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations.Melamine-related kidney stones and renal toxicity.The Janus face of PAMAM dendrimers used to potentially cure nonenzymatic modifications of biomacromolecules in metabolic disorders-a critical review of the pros and cons.Synthesis and characterization of a triazine dendrimer that sequesters iron(III) using 12 desferrioxamine B groups.Intercepting the synthesis of triazine dendrimers with nucleophilic pharmacophores: a general strategy toward drug delivery vehicles.Triazine dendrimers as nonviral gene delivery systems: effects of molecular structure on biological activity.Synthesis of efficient gene delivery systems by grafting pegylated alkylcarboxylate chains to PAMAM dendrimers: Evaluation of transfection efficiency and cytotoxicity in cancerous and mesenchymal stem cells.Encapsulation of a Concanavalin A/dendrimer glucose sensing assay within microporated poly (ethylene glycol) microspheres.Solubility of aceclofenac in polyamidoamine dendrimer solutions.Dendrimers Based on [1,3,5]-Triazines.Polycationic triazine-based dendrimers: effect of peripheral groups on transfection efficiencyDendrimer delivery of an anti-VEGF oligonucleotide into the eye: a long-term study into inhibition of laser-induced CNV, distribution, uptake and toxicity.Synthesis and evaluation of gadolinium complexes based on PAMAM as MRI contrast agents.Toxicity of melamine: the public health concern.Modulation of biogenic amines content by poly(propylene imine) dendrimers in rats.Toxicity of melamine, an adulterant in fish feeds: experimental assessment of its effects on tilapia.Chemical robotics — chemotactic drug carriersIn vivo toxicity of poly(propyleneimine) dendrimers
P2860
Q28550743-4A7C1165-84C0-4718-9E5D-007989FE8838Q30571992-00DF5DB0-3F9D-4CBE-A68A-CA775007DCE6Q34038519-BA411CFB-208A-4090-9E31-577DA394EEB2Q34054331-7309B2BE-1E70-4184-8E1C-4A56E3335A6DQ34464430-DC4D1267-3605-45B7-A0F8-B67BB8C7DF10Q34850437-71DFC7D1-A5A7-4474-9518-47A2381E056CQ35605967-A54D2B1C-608C-43BB-BCB9-0355029BA742Q36865560-21678826-E541-40DD-B8CA-43D1A995D927Q36917951-600B6C1C-67A7-4B21-93A8-4C56FBD4DFBAQ37234202-D9307FF9-39F9-4843-91C7-A863EB81035CQ37271236-0FED61D9-55E5-4F26-ABC7-786D26A24885Q37345372-0CC49AAB-B935-4EBB-98EC-A275A7E727DCQ37378029-D4DD5D25-7935-4A6D-8319-5462FFD53F5DQ37823446-496E9197-91CF-4614-A478-12688E180AFDQ37855527-6A8668C8-46AF-41F5-BBA6-15514788668CQ38161415-13D642DD-F085-46D7-AED8-35D4902331D1Q39672604-0EB9127A-E218-4DC4-99CB-02A0F3B73348Q39799761-56C02E5F-920D-4BF8-8A65-5F830AB15791Q39807995-49C1CBB0-84F7-4E54-A6DF-F51C6B77B0D0Q41490669-E0454EA4-4668-41AD-BB9D-939D10960EC2Q41888416-A60D6AF3-60D6-41FD-84B7-9F84FCCD1D61Q42142803-F423FDCD-1E56-4CA0-9350-4F3ACA949DFCQ42682043-6D43D9EF-D12E-4986-AC80-BC251CD5B9D7Q42686189-A924B12B-3654-4B48-9C6A-548CEF3332E5Q45885254-F562FCC1-4A4F-4BC7-BF10-4313B5D907A8Q46419803-F397C089-1381-4122-A8E7-05438923C4EBQ46977304-0BD9D1C5-74D0-4ED5-8151-D18EB8EA40FBQ48638069-04685DB2-4561-42AC-9AB7-8A3244C0D724Q50500243-7EFB3A5E-78EB-487F-B5E8-5F02405510D1Q56041128-59C2E075-613D-4FE8-8EB0-707D435BE003Q57777440-443E3234-1359-4BC1-921F-7F89B0367EAD
P2860
In vitro and in vivo evaluation of a melamine dendrimer as a vehicle for drug delivery.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
In vitro and in vivo evaluation of a melamine dendrimer as a vehicle for drug delivery.
@ast
In vitro and in vivo evaluation of a melamine dendrimer as a vehicle for drug delivery.
@en
type
label
In vitro and in vivo evaluation of a melamine dendrimer as a vehicle for drug delivery.
@ast
In vitro and in vivo evaluation of a melamine dendrimer as a vehicle for drug delivery.
@en
prefLabel
In vitro and in vivo evaluation of a melamine dendrimer as a vehicle for drug delivery.
@ast
In vitro and in vivo evaluation of a melamine dendrimer as a vehicle for drug delivery.
@en
P2093
P1476
In vitro and in vivo evaluation of a melamine dendrimer as a vehicle for drug delivery
@en
P2093
Eric E Simanek
Michael F Neerman
P304
P356
10.1016/J.IJPHARM.2004.04.023
P407
P577
2004-08-01T00:00:00Z